POTASSIUM CITRATE
These highlights do not include all the information needed to use POTASSIUM CITRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CITRATE EXTENDED-RELEASE TABLETS. POTASSIUM CITRATE extended-release tablets, for oral use Initial U.S. Approval: 1985
e49f812c-74e2-4ee7-80d8-57f7f93fe02b
HUMAN PRESCRIPTION DRUG LABEL
Jan 18, 2021
Ascent Pharmaceuticals Inc
DUNS: 080938961
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Potassium Citrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
Potassium Citrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
Potassium Citrate
Product Details
FDA regulatory identification and product classification information